Effects of ACEI and ARB on COVID-19 patients: A meta-analysis

BACKGROUND: The clinical use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) in patients with COVID-19 infection remains controversial. Therefore, we performed a meta-analysis on the effects of ACEI/ARB on disease symptoms and laboratory tests in hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yang, Sun, Shaoqing, Cai, Jianing, Zeng, Linwen, Wang, Shihui, Wang, Suhuai, Li, Jingjie, Sun, Lin, Huo, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
COVID-19 and the Renin-Angiotensin-Aldosterone System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747108/
https://www.ncbi.nlm.nih.gov/pubmed/33325306
http://dx.doi.org/10.1177/1470320320981321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747108/
https://www.ncbi.nlm.nih.gov/pubmed/33325306
http://dx.doi.org/10.1177/1470320320981321

Ejemplares similares